This ‘systematic overview of reviews’ assembled the evidence for stimulant use disorder treatments from the systematic reviews of literature.
Eight years joining CPDD drug problems conference
Some things in academia can become so much fabric of your life that you stop counting years. The conference of the College on Problems of Drug Dependence (CPDD) is one of those things. With the 2020 conference coming up soon, this blog summarises my annotated posters presented over eight years. (more…)
Can prescribers avoid contributing to opioid use disorder?
A 21 y/o has surgery for a condition expected to improve. He fills a discharge prescription for 5 days of an opioid at a standard dose. At 1-week follow-up with his family doctor for suture removal, he describes ongoing pain. Can prescribers avoid contributing to opioid use disorder? Is a renewal of opioid appropriate, potentially dangerous, or both? Read more …
Can prescribers avoid contributing to opioid use disorder?
Why Cochrane collaboration makes strongest researchers
So what has the Cochrane membership done for me? Inspired by Dr Jeremy Grimshaw’s question: “So what has the Cochrane Collaboration ever done for us?” I submit a report card, a mosaic of my previous blogs, on my first 10 years with Cochrane.
Missing Evidence on Addiction Medicine Professional Training Needs
We wanted to find out whether newly trained professionals working in addiction medicine around the world felt they had enough and appropriate training to treat individuals with addictions.
| QUICK FACT: There are international differences in the training quality and type given to professionals in addiction medicine, and their training needs. |